Drugs · Brain health technique

Senolytic Combinations

Evidence grade: Experimental

Illustration for Senolytic Combinations

Experimental drug combinations designed to selectively clear senescent (“zombie”) cells that accumulate with age and drive chronic inflammation. Leading examples include dasatinib + quercetin, fisetin, and navitoclax.

Practice
Drugs
Principle
Treatment
Tactic
Emerging Longevity / Neuroregenerative Agents
Evidence grade
Experimental
Strength of evidence
Low

How to practice Senolytic Combinations

Not FDA-approved for cognitive or aging use. Human dosing regimens are experimental (e.g., dasatinib 100 mg + quercetin 1,000 mg for 2–3 days monthly). Potential for off-target toxicity and cytopenias. Should only be pursued in formal clinical trials. Long-term cognitive efficacy remains speculative.

The evidence behind Senolytic Combinations

Senolytic drugs make senescent cells self-destruct. Clearing senescent cells cuts the inflammatory signals they release. That may lower inflammation and oxidative stress across the body and help tissues repair. In animals, treatment improves resilience. Human data are still emerging, mostly limited to short-term safety results.

Impact on brain health

In animal studies, memory and thinking improve after treatment. Lower inflammation and oxidative stress may also protect the brain, since both can speed up neurodegeneration. Human evidence for brain benefits is still early.

Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science

Pair this with other habits from the same practice.

  • Evidence grade: Context Dependent

    Anti-Amyloid Monoclonal Antibodies

    FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

    Medium effort

  • Evidence grade: Context Dependent

    Antihypertensives

    Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

    Low effort · High cost

  • Evidence grade: Context Dependent

    GLP-1 Receptor Agonists

    A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.

See all 20 drugs techniques →

Take control of your brain health

BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.

How BetterBrain worksSee pricing